awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q26796405-10F95065-0E54-4D69-B6DF-57A18895B9C5
Q26796405-10F95065-0E54-4D69-B6DF-57A18895B9C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796405-10F95065-0E54-4D69-B6DF-57A18895B9C5
Progress toward overcoming hypoxia-induced resistance to solid tumor therapy
P2860
Q26796405-10F95065-0E54-4D69-B6DF-57A18895B9C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796405-10F95065-0E54-4D69-B6DF-57A18895B9C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b7b97e824147eaccbfdddd2d48e109cb3afb6ad6
P2860
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors.